Skip to content

It is a study to see the effect of giving local anaesthesia drug in the intercostal space to block pain carrying nerves near the mid chest bone for reducing the pain after heart operation. it will be done using a imaging device for better visualization of the nerves.

ULTRASOUND GUIDED PARASTERNAL MODIFIED INTERCOSTAL NERVE BLOCK: ROLE AS A PREEMPTIVE ANALGESIC ADJUNT IN FAST TRACKING FOR MITIGATING POSTOPERATIVE STERNOTOMY PAIN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021305
Enrollment
90
Registered
2019-09-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I252- Old myocardial infarction

Interventions

Intervention1: PARASTERNAL INTERCOSTAL NERVE BLOCK: ULTRASOUND GUIDED INTERCOSTAL NERVE BLOCK. IT IS A SINGLE SHOT INJECTION TECHNIQUE WHERE 1 ML OF LOCAL ANAESTHETIC AGENT LEVOBUPIVACAINE WILL BE INJ

Sponsors

SCTIMST
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CABG 40-70 YRS

Exclusion criteria

Exclusion criteria: Emergency Surgeries. Redo-surgeries. Open Sternum Left Ventricular Ejection Fraction Preoperative use of narcotics or illicit drug abuse. History of chronic intractable non-cardiac pain. Liver or Kidney disease Allergy to Amide group of anaesthetics, Morphine or Fentanyl. Arrhythmia history or rhythm disturbances documented in ECG. Haemodynamically unstable patients already on preoperative inotropic support or Intra-arterial balloon pumps (IABP). Anticipated surgery or surgery lasting more than 6hrs. Intubation time more than 12hrs or planned for overnight ventilation. Patients refusing to participate. Patients refusing the offered therapeutic options in either group. Patients refusing for parting with medical data for analysis. Patients refusing to participate after the start of study and desire to leave the study at any point of time. Patients currently enrolled in another study. Patients with inability to provide informed written consent. Inability to complete Pain assessments. Post-operative complications with underlying cardio-respiratory cause requiring return to operative room for re-explorations or reinstitution of mechanical ventilation.

Design outcomes

Primary

MeasureTime frame
Quality and effectiveness of pain relief will beevaluated for 48 hrs after the surgery with routine in-hospital analgesic protocol using following parameters: 11-point 0-10 Verbal Numeric RatingEffects of the blockade on sedation, ventilation and requirement of concomitant analgesics will be assessed using following methods: a) Alertness of patients in peri-tracheal extubation period, as assessed by Ramsay Sedation score in the initial 48 hours after the block. Timepoint: Quality and effectiveness of pain relief will beevaluated for 48 hrs after the surgery with routine in-hospital analgesic protocol using following parameters: 11-point 0-10 Verbal Numeric RatingEffects of the blockade on sedation, ventilation and requirement of concomitant analgesics will be assessed using following methods: a) Alertness of patients in peri-tracheal extubation period, as assessed by Ramsay Sedation score in the initial 48 hours after the block.

Secondary

MeasureTime frame
1. Over-sedation leading to ETCO2 or PaCO2 build up during the ventilator weaning phase or peri-tracheal extubation period 2. Any requirement for temporary discontinuation of opioid infusion. 3. Any postoperative requirement for other supplemental analgesics Timepoint: 4 HRLY

Countries

India

Contacts

Public Contactsanthosh

SCTIMST

subin@sctimst.ac.in8289983726

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026